Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunohistochemistry of Cancers Publisher



Ghanadan A1, 2 ; Jahanzad I3 ; Abbasi A4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatopathology, Razi Dermatology Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pathology and Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pathology and Cancer Institute, Imam Khomeini Complex Hospital, School of Medicine and Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Pathology and Imam Khomeini Hospital, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Source: Cancer Immunology: A Translational Medicine Context# Second Edition Published:2020


Abstract

This chapter provides an overview of mostly malignant tumors of various organs with focus on the most common types. The authors have used their own experience in addition to literature review and have discussed the most common and useful immunohistochemistry markers in diagnosis and differential diagnosis of various malignant tumors. Novel prognostic markers are also included. © Springer Nature Switzerland AG 2020.
Related Docs
View other Related Docs
1. Immunohistochemistry of Cancers, Cancer Immunology: A Translational Medicine Context (2015)
2. Hurdles in Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
3. Genetic and Epigenetic Alterations in Parathyroid Neoplasms, Iranian Journal of Pathology (2022)
4. Targeting Regulatory T Cells by Curcumin: A Potential for Cancer Immunotherapy, Pharmacological Research (2019)
5. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
6. Cancer Immunology, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
7. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)
8. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (10)
Hamid Reza Mirzaei (1)
Other Related Docs
9. Cell-Based Vaccines: Frontiers in Medical Technology for Cancer Treatment, Regenerative Engineering and Translational Medicine (2024)
10. P16ink4a Immunohistochemistry As a Gold Standard for Cervical Cancer and Precursor Lesions Screening, Iranian Journal of Public Health (2020)
11. The Role of Cxc Chemokines and Receptors in Breast Cancer, Clinical and Experimental Medicine (2025)
12. Image-Based Multiplex Immune Profiling of Cancer Tissues: Translational Implications. a Report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer, Journal of Pathology (2024)
13. An Agent-Based Model of Avascular Tumor Growth: Immune Response Tendency to Prevent Cancer Development, Simulation (2017)
14. The Paradox of Th17 Cell Functions in Tumor Immunity, Cellular Immunology (2017)
15. Natural Killer Cells and Acute Myeloid Leukemia: Promises and Challenges, Cancer Immunology# Immunotherapy (2022)
16. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
17. Cancer Immunoprevention: Current Status and Future Directions, Archivum Immunologiae et Therapiae Experimentalis (2021)
18. Dysregulation of Helper T Lymphocytes in Esophageal Squamous Cell Carcinoma (Escc) Patients Is Highly Associated With Aberrant Production of Mir-21, Immunologic Research (2019)
19. Tumor Antigens, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)
20. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
21. Myeloid-Derived Suppressor Cells in Gastrointestinal Cancers: A Systematic Review, Journal of Gastroenterology and Hepatology (Australia) (2016)
22. Interdigitating Dendritic Cell Tumor of Submandibular Lymph Node: Case Report and Literature Review, Iranian Journal of Pathology (2021)
23. Adenoid Cystic Carcinoma and Polymorphus Adenocarcinoma: An Immunohistochemical Comparison, Iranian Journal of Science and Technology# Transaction A: Science (2021)
24. Tumor-Infiltrating Lymphocyte Therapy for Lung Cancer and Its Future Paradigms, Expert Opinion on Biological Therapy (2022)